rs8112895
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001130823.3(DNMT1):c.80+334T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 221,016 control chromosomes in the GnomAD database, including 2,871 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 2115 hom., cov: 32)
Exomes 𝑓: 0.11 ( 756 hom. )
Consequence
DNMT1
NM_001130823.3 intron
NM_001130823.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.196
Publications
12 publications found
Genes affected
DNMT1 (HGNC:2976): (DNA methyltransferase 1) This gene encodes an enzyme that transfers methyl groups to cytosine nucleotides of genomic DNA. This protein is the major enzyme responsible for maintaining methylation patterns following DNA replication and shows a preference for hemi-methylated DNA. Methylation of DNA is an important component of mammalian epigenetic gene regulation. Aberrant methylation patterns are found in human tumors and associated with developmental abnormalities. Variation in this gene has been associated with cerebellar ataxia, deafness, and narcolepsy, and neuropathy, hereditary sensory, type IE. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNMT1 Gene-Disease associations (from GenCC):
- autosomal dominant cerebellar ataxia, deafness and narcolepsyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary sensory neuropathy-deafness-dementia syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.417 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNMT1 | NM_001130823.3 | c.80+334T>C | intron_variant | Intron 1 of 40 | ENST00000359526.9 | NP_001124295.1 | ||
| DNMT1 | NM_001318730.2 | c.80+334T>C | intron_variant | Intron 1 of 39 | NP_001305659.1 | |||
| DNMT1 | NM_001379.4 | c.80+334T>C | intron_variant | Intron 1 of 39 | NP_001370.1 | |||
| DNMT1 | NM_001318731.2 | c.-244+334T>C | intron_variant | Intron 1 of 40 | NP_001305660.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNMT1 | ENST00000359526.9 | c.80+334T>C | intron_variant | Intron 1 of 40 | 1 | NM_001130823.3 | ENSP00000352516.3 |
Frequencies
GnomAD3 genomes AF: 0.139 AC: 21136AN: 152112Hom.: 2094 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
21136
AN:
152112
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.107 AC: 7381AN: 68786Hom.: 756 Cov.: 2 AF XY: 0.110 AC XY: 3878AN XY: 35176 show subpopulations
GnomAD4 exome
AF:
AC:
7381
AN:
68786
Hom.:
Cov.:
2
AF XY:
AC XY:
3878
AN XY:
35176
show subpopulations
African (AFR)
AF:
AC:
347
AN:
1932
American (AMR)
AF:
AC:
237
AN:
1348
Ashkenazi Jewish (ASJ)
AF:
AC:
287
AN:
3044
East Asian (EAS)
AF:
AC:
2056
AN:
5848
South Asian (SAS)
AF:
AC:
1050
AN:
5480
European-Finnish (FIN)
AF:
AC:
404
AN:
3600
Middle Eastern (MID)
AF:
AC:
21
AN:
376
European-Non Finnish (NFE)
AF:
AC:
2495
AN:
42492
Other (OTH)
AF:
AC:
484
AN:
4666
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
288
576
864
1152
1440
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.139 AC: 21215AN: 152230Hom.: 2115 Cov.: 32 AF XY: 0.147 AC XY: 10906AN XY: 74430 show subpopulations
GnomAD4 genome
AF:
AC:
21215
AN:
152230
Hom.:
Cov.:
32
AF XY:
AC XY:
10906
AN XY:
74430
show subpopulations
African (AFR)
AF:
AC:
8286
AN:
41532
American (AMR)
AF:
AC:
3049
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
375
AN:
3468
East Asian (EAS)
AF:
AC:
2225
AN:
5152
South Asian (SAS)
AF:
AC:
1044
AN:
4830
European-Finnish (FIN)
AF:
AC:
1485
AN:
10618
Middle Eastern (MID)
AF:
AC:
34
AN:
292
European-Non Finnish (NFE)
AF:
AC:
4384
AN:
68022
Other (OTH)
AF:
AC:
267
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
887
1775
2662
3550
4437
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
228
456
684
912
1140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1118
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.